The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of time to next treatment (TTNT) in melflufen and dexamethasone-treated patients (pts) with relapsed/refractory multiple myeloma (RRMM).
 
Sara Bringhen
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag
Consulting or Advisory Role - Celgene; Janssen-Cilag; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen-Cilag
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Takeda
Research Funding - Celgene; Takeda
 
Peter Michael Voorhees
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Speakers' Bureau - Celgene
 
Torben Plesner
Consulting or Advisory Role - Abbvie; Celgene; Genmab; Janssen; Takeda
Research Funding - Janssen
 
Ulf-Henrik Mellqvist
Honoraria - Amgen; Celgene; Janssen; Oncopeptides; Takeda
Consulting or Advisory Role - Amgen
 
Jeffrey A. Zonder
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen; Prothena; Seagen; Takeda
Research Funding - Celgene (Inst)
 
Brandi Nikcole Reeves
Employment - Select Specialty Hospital
Consulting or Advisory Role - Seagen
Speakers' Bureau - Celgene
Research Funding - Amgen; Celgene; GlaxoSmithKline; Janssen; Oncopeptides
 
Stojan Zavisic
Employment - Oncopeptides
Stock and Other Ownership Interests - Oncopeptides
 
Johan Harmenberg
Employment - Oncopeptides
Leadership - Oncopeptides
Stock and Other Ownership Interests - Oncopeptides
 
Jakob Obermüller
Employment - Oncopeptides
Stock and Other Ownership Interests - Oncopeptides
 
Pieter Sonneveld
Honoraria - Amgen; Celgene; Janssen; Seagen
Consulting or Advisory Role - Amgen; Celgene; Janssen; Seagen
Research Funding - Celgene; Janssen